Fuling Technology
001356
KLT
831689
Hand Enterprise Solutions
300170
4
GRANDTECH
835184
5
Doushen(Beijing) Education & Technology Inc.
300010
US Stock MarketDetailed Quotes
IONS Ionis Pharmaceuticals
- 32.500
- -0.180-0.55%
Close Jan 22 16:00 ET
5.13BMarket Cap-13.32P/E (TTM)
32.930High32.370Low1.05MVolume32.650Open32.680Pre Close34.30MTurnover0.67%Turnover RatioLossP/E (Static)157.90MShares52.49052wk High7.75P/B5.09BFloat Cap31.40052wk Low--Dividend TTM156.51MShs Float86.582Historical High--Div YieldTTM1.71%Amplitude2.500Historical Low32.587Avg Price1Lot Size
About Ionis Pharmaceuticals Company
Ionis Pharmaceuticals, Inc. engages in the development and commercialization of human therapeutic drugs using antisense technology. It operates through the Ionis Core segment. The Ionis Core segment exploits a novel drug discovery platform to generate a pipeline of drugs. The company was founded by Stanley T. Crooke, David J. Ecker, Christopher K. Mirabelli, and Brett P. Monia on January 10, 1989 and is headquartered in Carlsbad, CA.
Company Profile
SymbolIONS
Company NameIonis Pharmaceuticals
Listing DateApr 17, 1991
Issue Price57.56
Founded1989
CEODr. Brett P. Monia, PhD
MarketNASDAQ
Employees927
Fiscal Year Ends12-31
Address2855 Gazelle Court
CityCarlsbad
ProvinceCalifornia
CountryUnited States of America
Zip Code92010
Phone1-760-931-9200
Websitehttp://www.ionis.com
Company Executives
- Name
- Position
- Salary
- Dr. Brett P. Monia, PhD
- Chief Executive Officer and Director
- 12.50M
- Patrick R. O'Neil, Esq.
- Chief Legal Officer, General Counsel and Corporate Secretary
- --
- Joseph T. Baroldi
- Executive Vice President and Chief Business Officer
- --
- Dr. C. Frank Bennett,PhD
- Executive Vice President and Chief Scientific Officer
- --
- Elizabeth L. Hougen
- Executive Vice President, Finance, Principal Accounting Officer and Chief Financial Officer
- 2.89M
- Dr. Richard S. Geary,PhD
- Executive Vice President and Chief Development Officer
- 2.56M
- Eugene Schneider
- Executive Vice President and Chief Clinical Development and Operations Officer
- --
- Kyle Jenne
- Executive Vice President, Commercial
- --
- Eric E. Swayze, PhD
- Executive Vice President, Research
- 2.56M
- Brian Birchler
- Executive Vice President, Corporate and Development Operations
- --
- Dr. Joseph Loscalzo, M.D.,PhD
- Chairman of the Board
- 568.04K
- B. Lynne Parshall, Esq.,J.D.
- Director
- 538.04K
- Joseph Klein, III
- Independent Director
- 542.04K
- Allene M. Diaz
- Independent Director
- 530.04K
- Michael J. Yang
- Independent Director
- 363.05K
- Dr. Michael Hayden
- Independent Director
- 528.04K
- Joseph H. Wender
- Lead Independent Director
- 598.04K
- Joan E. Herman
- Independent Director
- 540.04K
- Dr. Spencer R. Berthelsen,M.D.
- Independent Director
- 548.04K
Trending Stocks
Investment Course
Top 5 Industries for Stock Trading under Trump's Second Term
Stocks & Industries to Watch Under Trump's Second Presidency
With mooomoo, find out which stocks and industries may benefit from Trump's second presidency, based on his first administration's track record.
Stocks & Industries to Watch Under Trump's Second Presidency
Key takeaways Tech stocks underwent substantial growth due to tax cuts and reduced corporate regulations in Trump's first term along with defense and aerospace
Discussing
December CPI comes in as expected, is that enough?
U.S. December CPI rose 2.9% year-on-year, aligning with expectations but marking a three-month inflation increase trend. The market reacted
In One Chart
Jan 15 22:05
Here's the Breakdown for December CPI, in One Chart